Skip to main content
OpenTrials
Completed

NCT Number: NCT05622513

Phthalate Esters and Childhood Obesity

Phthalate esters have been considered closely related with childhood obesity, but the existing studies revealed inconsistent results. This study was desigened to investigate the association between phthalate esters and childhood obesity in China.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The physical activity, dietary intake and the levels of urine phthalate metabolites of children were detected, and the associations between these 3 factors and childhood obesity were analyzed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children who were classified as normal, overweight and obesity based on age, gender and BMI.

Exclusion criteria

  • The participants who were with endocrine disorders.

Treatment and study plan

Primary outcomes

  1. the levels of urine phthalate metabolites

    Time frame: 3 months

    9 phthalate metabolites (MMP, MEP, MnBP, MiBP, MEHP, MEOHP, MEHHP, MCEPP, MCMHP) in first morning urine sample of the participants were detected

Sponsors and collaborators

Lead sponsor

Shenzhen Center for Disease Control and Prevention

Other Gov

Registry information

Official study title

the Association Between Phthalate Esters and Childhood Obesity

Important dates

Study start
2016
Primary completion
2017
Study completion
2022
First posted
Nov 18, 2022
Registry last updated
Nov 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.